(VIANEWS) – Shares of HOFSETH BIOCARE (Oslo Børs Benchmark Index_GI: HBC.OL) rose by a staggering 22.4% in 10 sessions from kr2.5 to kr3.06 at 13:38 EST on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI is jumping 0.54% to kr1,249.22, after two consecutive sessions in a row of gains.
HOFSETH BIOCARE’s last close was kr2.88, 46.86% below its 52-week high of kr5.42.
About HOFSETH BIOCARE
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for supporting healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome (IBS) and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo, an hair, skin, and nails health treatment and antioxidant; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.
Earnings Per Share
As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.78%.
Volume
Today’s last reported volume for HOFSETH BIOCARE is 184259 which is 31.16% below its average volume of 127327.
Moving Average
HOFSETH BIOCARE’s value is higher than its 50-day moving average of kr2.89 and below its 200-day moving average of kr3.27.
More news about HOFSETH BIOCARE (HBC.OL).
